Dose | Locomotor Activity | Risk Assessment | Defensive Attack | Contextual Defense | |||||
---|---|---|---|---|---|---|---|---|---|
Line Crossings | Stops | Orientations | Approaches-Withdrawals | Bitings | Escape Attempts | ||||
mg/kg | |||||||||
Acute Experiments | |||||||||
SL651498 (i.p.) | 0 | 107.3 ± 12.5 | 11.6 ± 1.6 | 8.9 ± 1.8 | 1.1 ± 0.2 | 2.5 ± 0.3 | 35.1 ± 2 | ||
1 | 137 ± 6 | 11.1 ± 1.4 | 8.2 ± 1.4 | 1.3 ± 0.4 | 2.7 ± 0.1 | 30.5 ± 2.3 | |||
3 | 143.5 ± 12.5 | 11.8 ± 2 | 9.8 ± 1.8 | 1.5 ± 0.3 | 2.3 ± 0.3 | 26.9 ± 2.8 | |||
10 | 121.6 ± 8.2 | 5.2 ± 1.26-150 | 4 ± 1.26-150 | 1.5 ± 0.4 | 0.8 ± 0.36-150 | 11.8 ± 2.26-150 | |||
Diazepam (i.p.) | 0 | 127.6 ± 9.6 | 13.3 ± 2 | 9.6 ± 1.9 | 0 ± 0 | 2.3 ± 0.3 | 30.6 ± 3.8 | ||
0.5 | 138.6 ± 16.1 | 10.1 ± 1.4 | 5.9 ± 1.5 | 0.3 ± 0.2 | 1.8 ± 0.2 | 27.3 ± 4.9 | |||
1 | 139.5 ± 22 | 3.6 ± 0.66-150 | 2.3 ± 0.66-150 | 0.8 ± 0.3 | 0.8 ± 0.26-150 | 24.5 ± 5.4 | |||
3 | 95.1 ± 13.7 | 3.1 ± 0.86-150 | 1.3 ± 0.46-150 | 1.6 ± 0.66-150 | 0.1 ± 0.16-150 | 19 ± 5.8 | |||
SL651498 (p.o.) | 0 | 123.6 ± 10 | 9.8 ± 0.2 | 6.7 ± 1.1 | 0 ± 0 | 2.6 ± 0.2 | 35.2 ± 11.7 | ||
3 | 120.9 ± 9 | 8.9 ± 0.2 | 5.4 ± 0.46-150 | 0 ± 0 | 2 ± 0.26-150 | 32.6 ± 10.9 | |||
10 | 111.7 ± 8 | 6.2 ± 0.46-150 | 3 ± 0.36-150 | 0.1 ± 0.1 | 0.1 ± 0.16-150 | 17.4 ± 5.86-150 | |||
30 | 99.7 ± 10.9 | 5 ± 0.66-150 | 1.8 ± 0.46-150 | 0.6 ± 0.36-150 | 0.1 ± 0.16-150 | 16.1 ± 5.46-150 | |||
Diazepam (p.o.) | 0 | 153.3 ± 8.2 | 9.3 ± 0.2 | 6.9 ± 0.5 | 0.1 ± 0.1 | 2.6 ± 0.2 | 37.2 ± 3.7 | ||
1 | 153.3 ± 9.2 | 8.8 ± 0.3 | 5.5 ± 0.56-150 | 0.2 ± 0.1 | 2.2 ± 0.3 | 29.7 ± 2.9 | |||
3 | 136.6 ± 7.2 | 6.6 ± 0.36-150 | 3.3 ± 0.56-150 | 0.7 ± 0.3 | 0.3 ± 0.26-150 | 18.8 ± 3.56-150 | |||
10 | 111.3 ± 4.86-150 | 5.2 ± 0.36-150 | 1.4 ± 0.36-150 | 2.3 ± 0.46-150 | 0 ± 06-150 | 3.2 ± 1.26-150 | |||
20 | 111.1 ± 86-150 | 4.8 ± 0.46-150 | 1.3 ± 0.36-150 | 2.6 ± 0.56-150 | 0 ± 06-150 | 4.2 ± 2.26-150 | |||
Repeated Experiments | |||||||||
SL651498 (acute, p.o.) | 0 | 116.6 ± 10.3 | 6.8 ± 1.2 | 9.3 ± 0.8 | 0.1 ± 0.1 | 2.5 ± 0.2 | 30.1 ± 5.4 | ||
1 | 103.6 ± 10.2 | 5.6 ± 1 | 8.3 ± 1 | 0.9 ± 0.4 | 1.4 ± 0.3 | 26.8 ± 3.2 | |||
3 | 122.4 ± 12.9 | 4.8 ± 1.1 | 6.8 ± 1 | 0.8 ± 0.3 | 1.3 ± 0.46-150 | 23 ± 3.2 | |||
10 | 110.0 ± 8.7 | 2.1 ± 0.56-150 | 4.4 ± 0.66-150 | 0.5 ± 0.3 | 0.3 ± 0.26-150 | 21.3 ± 3.9 | |||
Diazepam (acute, p.o.) | 3 | 94.1 ± 7.2 | 1.6 ± 0.66-150 | 3.4 ± 0.76-150 | 1.5 ± 0.5 | 0 ± 06-150 | 16 ± 4.6 | ||
SL651498 (repeated, p.o.) | 1 | 90.9 ± 10.8 | 4.4 ± 0.9 | 6.9 ± 0.7 | 0.4 ± 0.2 | 1.8 ± 0.4 | 24.9 ± 2.7 | ||
3 | 119.4 ± 9.1 | 3.8 ± 0.76-150 | 5.4 ± 0.96-150 | 1 ± 0.4 | 0.8 ± 0.56-150 | 22.9 ± 5 | |||
10 | 103.9 ± 5.3 | 4.4 ± 0.8 | 6.5 ± 16-150 | 1.3 ± 0.4 | 0 ± 06-150 | 24.1 ± 3.4 | |||
Diazepam (repeated, p.o.) | 3 | 104 ± 11.5 | 3.4 ± 0.66-150 | 5.1 ± 0.76-150 | 1.4 ± 0.4 | 0 ± 06-150 | 20.9 ± 3.5 |
Data represent mean ± SEM. n = 8 to 12.
↵6-150 P < 0.05 (relative to zero drug treatment, Dunnett's t test).